Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · IEX Real-Time Price · USD
4.130
-0.130 (-3.05%)
Jul 22, 2024, 10:05 AM EDT - Market open
Jaguar Health Employees
Jaguar Health had 49 employees as of December 31, 2023. The number of employees decreased by 11 or -18.33% compared to the previous year.
Employees
49
Change (1Y)
-11
Growth (1Y)
-18.33%
Revenue / Employee
$206,939
Profits / Employee
-$782,122
Market Cap
20.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Singular Genomics Systems | 255 |
Cosmos Health | 102 |
Cumberland Pharmaceuticals | 91 |
BiomX | 71 |
Oncternal Therapeutics | 30 |
AIM ImmunoTech | 28 |
Iterum Therapeutics | 14 |
TRxADE HEALTH | 8 |
JAGX News
- 3 days ago - Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning - Accesswire
- 26 days ago - Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement - Accesswire
- 4 weeks ago - Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders - Accesswire
- 5 weeks ago - Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024 - Accesswire
- 6 weeks ago - Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Accesswire
- 2 months ago - Jaguar Health, Inc. Announces Reverse Stock Split - Accesswire
- 2 months ago - Jaguar Health Reports First Quarter 2024 Financial Results - Accesswire
- 2 months ago - REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates - Accesswire